TrimRx's Blog

Ozempic isn’t approved for type 1 diabetes because it doesn’t replace insulin — it enhances existing beta-cell function, which type 1 patients lack

Ozempic isn’t FDA-approved for prediabetes, but off-label use is common. Here’s what the evidence shows about efficacy, safety, and alternatives.

Ozempic reduces major cardiovascular events by 20% in high-risk patients, but proper monitoring matters. Here’s what the SELECT trial actually shows.

Ozempic (semaglutide) showed 59% NASH resolution versus 17% placebo in NEJM-published trials — liver fat reduction extends beyond weight loss alone.

Ozempic improves insulin sensitivity through GLP-1 receptor activation, reducing hepatic glucose output and enhancing peripheral glucose uptake in muscle

Semaglutide reduces liver fat by up to 40% in NAFLD patients — through mechanisms beyond weight loss alone. Here’s what the clinical evidence shows.

The Ozempic maintenance dose typically ranges from 0.5mg to 1.0mg weekly to sustain weight loss and glycemic control after initial titration completes.

Ozempic doesn’t directly treat thyroid conditions but carries specific thyroid-related risks including rare medullary thyroid carcinoma warnings requiring

Ozempic and statins can be taken together safely under medical supervision — no direct drug interaction exists, but both affect metabolic pathways